AA
COLL icon

ALPS Advisors’s Collegium Pharmaceutical COLL Stock Holding History

ALPS Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$527K Buy
14,552
+202
+1% +$6.9K ﹤0.01% 960
2026
Q1 		$475K Buy
+14,350
New +$608K ﹤0.01% 903
2025
Q1 		– Sell
-9,454
Closed -$271K – 1025
2024
Q4 		$271K Sell
9,454
-200
-2% -$6.62K ﹤0.01% 948
2024
Q3 		$373K Buy
9,654
+439
+5% +$15.7K ﹤0.01% 726
2024
Q2 		$297K Sell
9,215
-55
-0.6% -$1.91K ﹤0.01% 851
2024
Q1 		$360K Buy
+9,270
New +$324K ﹤0.01% 767
2019
Q3 		– Sell
-22,320
Closed -$294K – 855
2019
Q2 		$294K Sell
22,320
-1,176
-5% -$15.7K ﹤0.01% 844
2019
Q1 		$356K Buy
+23,496
New +$376K ﹤0.01% 852

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

ALPS Advisors's COLL Position: Q2 2026 in Review

ALPS Advisors increased its Collegium Pharmaceutical (COLL) stake by 1.4% in Q2 2026, buying an estimated $6.9K and bringing the position to 14,552 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #960.

ALPS Advisors first reported a position in COLL in Q1 2019 and has held it in 8 quarters since. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • ALPS Advisors held 14,552 shares of Collegium Pharmaceutical worth $527K as of Q2 2026.
  • ALPS Advisors bought 202 Collegium Pharmaceutical shares in Q2 2026, an estimated $6.9K.
  • Collegium Pharmaceutical made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #960 holding.
  • ALPS Advisors first reported a position in Collegium Pharmaceutical in Q1 2019 and has held it in 8 quarters since.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.